CAM
Cormorant Asset Management’s Theravance Biopharma TBPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-300,000
| Closed | -$4.36M | – | 101 |
|
|
2021
Q2 | $4.36M | Sell |
300,000
-250,000
| -45% | -$3.63M | 0.15% | 82 |
|
|
2021
Q1 | $11.2M | Hold |
550,000
| – | – | 0.25% | 64 |
|
|
2020
Q4 | $9.77M | Sell |
550,000
-100,072
| -15% | -$1.78M | 0.23% | 61 |
|
|
2020
Q3 | $9.61M | Buy |
650,072
+550,072
| +550% | +$8.13M | 0.37% | 55 |
|
|
2020
Q2 | $2.1M | Hold |
100,000
| – | – | 0.08% | 72 |
|
|
2020
Q1 | $2.31M | Buy |
100,000
+50,000
| +100% | +$1.16M | 0.11% | 62 |
|
|
2019
Q4 | $1.3M | Buy |
+50,000
| New | +$1.3M | 0.05% | 60 |
|
|
2019
Q1 | – | Sell |
-884,916
| Closed | -$22.6M | – | 70 |
|
|
2018
Q4 | $22.6M | Sell |
884,916
-215,084
| -20% | -$5.5M | 1.84% | 16 |
|
|
2018
Q3 | $35.9M | Sell |
1,100,000
-200,000
| -15% | -$6.53M | 2.34% | 15 |
|
|
2018
Q2 | $29.5M | Hold |
1,300,000
| – | – | 2.18% | 15 |
|
|
2018
Q1 | $31.5M | Buy |
1,300,000
+400,000
| +44% | +$9.7M | 2.35% | 10 |
|
|
2017
Q4 | $25.1M | Sell |
900,000
-50,000
| -5% | -$1.39M | 2.63% | 9 |
|
|
2017
Q3 | $32.5M | Hold |
950,000
| – | – | 5.74% | 5 |
|
|
2017
Q2 | $37.8M | Sell |
950,000
-475,000
| -33% | -$18.9M | 6.27% | 2 |
|
|
2017
Q1 | $52.5M | Hold |
1,425,000
| – | – | 7.62% | 1 |
|
|
2016
Q4 | $45.4M | Buy |
1,425,000
+306,628
| +27% | +$9.78M | 6.12% | 2 |
|
|
2016
Q3 | $40.5M | Hold |
1,118,372
| – | – | 4.47% | 3 |
|
|
2016
Q2 | $25.4M | Buy |
+1,118,372
| New | +$25.4M | 3.6% | 7 |
|